Neuromodulation Market Size, Share and Growth Analysis 2029

Name: Neuromodulation Market By Biomaterials (Metallic, Polymeric and Ceramic Biomaterials) By Technology (Internal Neuromodulation, External Neuromodulation) and by Region Global Trends and Forecast From 2022 To 2029
Price: 3499 USD
Availability: InStock
Rating: 4.5 (100 reviews)
Author: Exactitude Consultancy
ISBN: 23625

Neuromodulation Market Overview

The global neuromodulation market is expected to grow at a 12.3% CAGR from 2022 to 2029, from USD 5.79 billion in 2021.

Globally, neurological disorders like Parkinson's disease, epilepsy, chronic pain, and incontinence are on the rise. Worldwide, neurological disorders affect about 1 billion people, according to the World Health Organisation. Due to changing lifestyles and an ageing population, this number is anticipated to rise.

These therapies are becoming more widely accepted and used as a result of new neuromodulation technologies like closed-loop systems and wireless devices that make them more usable and accessible. Additionally, as the world's population ages and the prevalence of chronic diseases like chronic pain and movement disorders rises, neuromodulation therapies are expected to become more and more popular. This is especially true in developing nations, where there may be limited access to conventional drug therapies and a growing demand for cutting-edge, affordable treatment options.

ATTRIBUTE	DETAILS
Study period	2020-2029
Base year	2021
Estimated year	2022
Forecasted year	2022-2029
Historical period	2018-2020
Unit	Value (USD Billion)
Segmentation	By Biomaterials, By Technology, By Application, By Region.
By Biomaterials	Metallic Biomaterials Polymeric Biomaterials Ceramic Biomaterials
By Technology	Internal Neuromodulation External Neuromodulation
By Application	Chronic Pain Urinary And Fecal Incontinence Migraine Failed Back Syndrome Parkinson Disease Epilepsy Tremor Depression Other Applications
By Region	North America Europe Asia Pacific South America Middle East and Africa

The demand for neuromodulation devices is anticipated to increase, particularly as the prevalence of neurological disorders keeps rising. Neuromodulation therapies continue to be accepted and recognized as effective and secure treatment options. In the upcoming years, the market is anticipated to expand due to the rising demand for neuromodulation treatments

Neuromodulation can be used as an alternative to long-term drug therapy for the symptomatic relief of chronic or persistent conditions when the drugs are ineffective or problematic for the patient. By successfully modifying the abnormal neural pathway behaviour brought on by the disease process, neuromodulation devices stimulate the nerves with electrical signals, pharmaceutical agents, and other forms of energy. Neuromodulation therapies can prevent the negative effects of more systemic or irreversible treatments of nervous system disorders as they are tailored to the individual patient. Since they are easily reversible, they can also provide clinicians and patients with a fundamental level of therapeutic control.

The neuromodulation market has been significantly impacted by the COVID-19 pandemic in the healthcare sector. During the pandemic, many hospitals and clinics delayed non-emergency surgeries and procedures, including those involving neuromodulation. As a result, fewer neuromodulation procedures are being carried out, which has an impact on the market.

Market expansion is expected to be hampered by high costs, governmental restrictions, safety worries, and consumer ignorance. The surgical implantation of neuromodulation devices entails risks like infection, bleeding, or device malfunction. The use of these devices may be restricted due to safety concerns, or regulatory oversight may become more intense. Additionally, as neuromodulation is a young field, patients and medical professionals might not be as familiar with its potential advantages.

Some manufacturers are creating less invasive, more cost-effective neuromodulation devices that are simpler to use, which can help cut costs. Additionally, in order to increase the affordability and accessibility of neuromodulation therapies, some healthcare providers are looking into alternative payment models like value-based pricing. Therefore, despite the fact that access for patients in need of these treatments is currently hindered by the high cost of neuromodulation devices and therapies, efforts are being made to address this problem.

[caption id="attachment_23635" align="aligncenter" width="1920"]

Neuromodulation Market | Exactitude Consultancy[/caption]

Frequently Asked Questions

• What is the worth of global neuromodulation market?

The neuromodulation market reached USD 5.15 billion in 2020 and is expected to grow at a CAGR of more than 12.3% through 2029, owing to the increasing in awareness about health.

• What are the upcoming trends of neuromodulation market, globally?

The upcoming trend in the neuromodulation market is an opportunity for market growth.

• What is the CAGR of neuromodulation market?

The global neuromodulation market registered a CAGR of 12.3% from 2022 to 2029.

• Which are the top companies to hold the market share in neuromodulation market?

Key players profiled in the report include neuromodulation market are LivaNova PLC, Nevro Corporation, Medtronic, NeuroSigma, Neuronetics, Bioventus Inc., NeuroPace Inc, MicroTransponder, Boston Scientific Corporation and Abbott.

• Which is the largest regional market for neuromodulation market?

The North America neuromodulation market had largest market share of 47% in 2021. Increased availability of neuromodulation devices, a rising number of diseases (such as migraine), more neuromodulation device manufacturers in the US, and skilled medical professionals resulted in North America’s dominance in the industry.

Key Question Answered

What is the expected growth rate of the neuromodulation market over the next 7 years?
Who are the major players in the neuromodulation market and what is their market share?
What are the end-user industries driving demand for market and what is their outlook?
What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
How is the economic environment affecting the neuromodulation market, including factors such as interest rates, inflation, and exchange rates?
What is the expected impact of government policies and regulations on the neuromodulation market?
What is the current and forecasted size and growth rate of the global neuromodulation market?
What are the key drivers of growth in the neuromodulation market?
Who are the major players in the market and what is their market share?
What are the distribution channels and supply chain dynamics in the neuromodulation market?
What are the technological advancements and innovations in the neuromodulation market and their impact on product development and growth?
What are the regulatory considerations and their impact on the market?
What are the challenges faced by players in the neuromodulation market and how are they addressing these challenges?
What are the opportunities for growth and expansion in the neuromodulation market?
What are the service offerings and specifications of leading players in the market?

Neuromodulation Market Segment Analysis

Implanting neuromodulation and neurostimulation devices is becoming more common to normalise nervous system activity and treat neurological condition symptoms. An NCBI study found that each year, about 50,000 spinal cord neurostimulators are used to treat patients who suffer from severe and persistent pain brought on by a variety of conditions, including failed back surgery/arachnoiditis, neuropathy, and other neurological disorders. Recent years have seen an increase in the use of spinal cord stimulators, which have a 74% long-term success rate. The neuromodulation market is segmented into three categories based on biomaterials: metallic, polymeric, and ceramic biomaterials, with metallic biomaterials making up the majority of the market. Metallic biomaterials are frequently used in neuromodulation devices, especially in electrodes and other parts that need to be durable and have high electrical conductivity. Due to their excellent biocompatibility, high strength-to-weight ratio, and resistance to corrosion, titanium and its alloys, in particular, are frequently used in neuromodulation devices. The neuromodulation market is segmented into internal and external neuromodulation based on technology, with internal neuromodulation making up the majority of the market. In general, internal neuromodulation is thought to be more successful in treating chronic conditions. External neuromodulation, on the other hand, is frequently used as a pain relief or diagnostic tool. [caption id="attachment_23644" align="aligncenter" width="1920"]

Neuromodulation Market | Exactitude Consultancy[/caption]

In order to deliver electrical or chemical stimulation to the nervous system, internal neuromodulation involves inserting devices into the patient's body. Common applications for these devices include the treatment of neurological conditions, movement disorders, and chronic pain. Spinal cord stimulators, deep brain stimulators, and sacral nerve stimulators are a few examples of internal neuromodulation devices.

The neuromodulation market is segmented by application into chronic pain, faecal and urinary incontinence, migraine, failed back syndrome, Parkinson disease, epilepsy, tremor, depression, and other applications, with chronic pain making up the majority of the market. One of the most prevalent chronic diseases, chronic pain, is primarily treated with neuromodulation therapies. The World Health Organisation estimates that chronic diseases like diabetes, heart disease, cancer, chronic respiratory diseases, and stroke cause roughly 71% of all deaths worldwide.

The industry size for pain management was the largest in 2021, at over 67%. The high prevalence of chronic pain disorders (like arthritis) and the rising demand for pain-management products as of their high and rising therapeutic value are expected to fuel the expansion of this market. Approximately 58.5 million people in the US, or 23.8% of the population, have arthritis, according to the CDC.

Neuromodulation therapies are also used to treat Parkinson's disease, epilepsy, depression, and urinary/faecal incontinence in addition to chronic pain. These conditions may be resistant to conventional treatments and have a significant impact on a patient's quality of life.

Neuromodulation Market Players

Key players involved in Neuromodulation market are LivaNova PLC, Nevro Corporation, Medtronic, NeuroSigma, Neuronetics, Bioventus Inc., NeuroPace Inc, MicroTransponder, Boston Scientific Corporation and Abbott. Mergers and acquisitions, joint ventures, capacity expansions, significant distribution, and branding decisions by established industry players to boost market share and regional presence. They are also engaged in continuous R&D activities to develop new Product Products and are focused on expanding the Product Biomaterials portfolio. This is expected to increase competition and pose a threat to new market entrants.

March 7, 2023, Nevro announced the full market launch of the revolutionary HFX IQTM spinal cord stimulation system in the United States to personalize chronic pain treatment.

March 1, 2023, NeuroSigma announced a new telehealth option for monarch eTNS for paediatric ADHD patients and carers.

Who Should Buy? Or Key stakeholders

Research and development
Hospitals & Specialty Cardiac Centers
Clinics & Physiotherapy Centers
Office-Based Labs
Government
Healthcare
Hospitals & Ambulatory Surgery Centers

Neuromodulation Market Regional Analysis

Geographically, the Neuromodulation market is segmented into North America, South America, Europe, APAC and MEA.

North America: includes the US, Canada, Mexico
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

[caption id="attachment_23645" align="aligncenter" width="1920"]

Neuromodulation Market | Exactitude Consultancy[/caption]

The market is dominated by North America, primarily as of the high prevalence of neurological disorders like Parkinson's disease and chronic pain, as well as the rising use of neuromodulation therapies by healthcare professionals. The region also has a large number of important market participants for neuromodulation, which supports its dominant position.

The Asia-Pacific region is predicted to have the highest CAGR as of the high patient population, rising healthcare spending, and growing knowledge of neuromodulation therapies. Significant investments are being made in the region's research and development of neuromodulation therapies and devices. Due to their large patient populations and rising use of neuromodulation therapies, Japan and China currently have the largest markets in the region. However, the market is also expanding significantly in other nations in the region, including Australia, South Korea, and India.

In developing nations like India, Brazil, and China, the prevalence of neurological conditions like epilepsy, depression, and others is rising. 54 million people in China are depressed, according to the WHO. However, fewer people have access to neuromodulation devices due to lower diagnosis and treatment rates, which restrains market expansion.

The prevalence of neurological, respiratory, and other conditions is currently rising throughout the world. The WHO estimates that 40–50 million people worldwide suffer from epilepsy, while Johns Hopkins Medicine estimates that 12 million people do. According to the Cystic Fibrosis Foundation, more than 30,000 people in America and more than 70,000 people worldwide have cystic fibrosis.

The demand for cooling equipment in a variety of end-user industries is significant in Europe, another significant market for chillers. The market is being driven by the rise in neurological conditions like epilepsy and depression. In the upcoming years, demand for neuromodulation therapies is anticipated to increase due to the region's sizable ageing population.

Key Market Segments: Neuromodulation Market

Neuromodulation Market By Biomaterials, 2020-2029, (USD Billion)

Metallic Biomaterials
Polymeric Biomaterials
Ceramic Biomaterials

Neuromodulation Market By Technology, 2020-2029, (USD Billion)

Internal Neuromodulation
External Neuromodulation

Neuromodulation Market By Application, 2020-2029, (USD Billion)

Chronic Pain
Urinary And Fecal Incontinence
Migraine
Failed Back Syndrome
Parkinson Disease
Epilepsy
Tremor
Depression
Other Applications

Neuromodulation Market By Regions, 2020-2029, (USD Billion)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered

Key Objectives:

Increasing sales and market share
Developing new Application
Improving profitability
Entering new markets
Enhancing brand reputation

TABLE OF CONTENTS

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS

RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES

EXECUTIVE SUMMARY

MARKET OVERVIEW
1. GLOBAL NEUROMODULATION MARKET OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON NEUROMODULATION MARKET
3. PORTER’S FIVE FORCES MODEL
  - THREAT FROM NEW ENTRANTS
  - THREAT FROM SUBSTITUTES
  - BARGAINING POWER OF SUPPLIERS
  - BARGAINING POWER OF CUSTOMERS
  - DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS

GLOBAL NEUROMODULATION MARKET BY BIOMATERIAL, 2020-2029, (USD BILLION)
1. METALLIC BIOMATERIALS
2. POLYMERIC BIOMATERIALS
3. CERAMIC BIOMATERIALS

GLOBAL NEUROMODULATION MARKET BY TECHNOLOGY, 2020-2029, (USD BILLION)
1. INTERNAL NEUROMODULATION
2. EXTERNAL NEUROMODULATION

GLOBAL NEUROMODULATION MARKET BY APPLICATION, 2020-2029, (USD BILLION)
1. CHRONIC PAIN
2. URINARY AND FECAL INCONTINENCE
3. MIGRAINE
4. FAILED BACK SYNDROME
5. PARKINSON DISEASE
6. EPILEPSY
7. TREMOR
8. DEPRESSION
9. OTHER APPLICATIONS

GLOBAL NEUROMODULATION MARKET BY REGION, 2020-2029, (USD BILLION)
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. SOUTH-EAST ASIA
  7. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRIC

COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)

9.1 LIVANOVA PLC

9.2. NEVRO CORPORATION

9.3. MEDTRONIC

9.4. NEUROSIGMA

9.5. NEURONETICS

9.6. BIOVENTUS INC.

9.7. NEUROPACE INC

9.8. MICROTRANSPONDER

9.9. BOSTON SCIENTIFIC CORPORATION

9.10. ABBOTT

*THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1                GLOBAL NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 2                GLOBAL NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 3                GLOBAL NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 4                GLOBAL NEUROMODULATION MARKET BY REGION (USD BILLION) 2020-2029

TABLE 5                NORTH AMERICA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 6                NORTH AMERICA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 7                NORTH AMERICA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 8                NORTH AMERICA NEUROMODULATION MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 9                US NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 10              US NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 11              US NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 12              CANADA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 13              CANADA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 14              CANADA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 15              MEXICO NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 16              MEXICO NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 17              MEXICO NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 18              SOUTH AMERICA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 19              SOUTH AMERICA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 20              SOUTH AMERICA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 21              SOUTH AMERICA NEUROMODULATION MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 22              BRAZIL NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 23              BRAZIL NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 24              BRAZIL NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 25              ARGENTINA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 26              ARGENTINA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 27              ARGENTINA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 28              COLUMBIA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 29              COLUMBIA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 30              COLUMBIA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 31              REST OF SOUTH AMERICA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 32              REST OF SOUTH AMERICA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 33              REST OF SOUTH AMERICA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 34              ASIA PACIFIC NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 35              ASIA PACIFIC NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 36              ASIA PACIFIC NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 37              ASIA PACIFIC NEUROMODULATION MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 38              INDIA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 39              INDIA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 40              INDIA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 41              CHINA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 42              CHINA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 43              CHINA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 44              JAPAN NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 45              JAPAN NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 46              JAPAN NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 47              SOUTH KOREA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 48              SOUTH KOREA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 49              SOUTH KOREA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 50              AUSTRALIA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 51              AUSTRALIA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 52              AUSTRALIA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 53              SOUTH EAST ASIA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 54              SOUTH EAST ASIA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 55              SOUTH EAST ASIA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 56              REST OF ASIA PACIFIC NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 57              REST OF ASIA PACIFIC NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 58              REST OF ASIA PACIFIC NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 59              EUROPE NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 60              EUROPE NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 61              EUROPE NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 62              EUROPE NEUROMODULATION MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 63              GERMANY NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 64              GERMANY NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 65              GERMANY NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 66              UK NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 67              UK NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 68              UK NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 69              FRANCE NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 70              FRANCE NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 71              FRANCE NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 72              ITALY NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 73              ITALY NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 74              ITALY NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 75              SPAIN NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 76              SPAIN NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 77              SPAIN NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 78              RUSSIA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 79              RUSSIA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 80              RUSSIA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 81              REST OF EUROPE NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 82              REST OF EUROPE NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 83              REST OF EUROPE NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 84              MIDDLE EAST & AFRICA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 85              MIDDLE EAST & AFRICA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 86              MIDDLE EAST & AFRICA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 87              MIDDLE EAST & AFRICA NEUROMODULATION MARKET BY COUNTRY (USD BILLION) 2020-2029

TABLE 88              UAE NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 89              UAE NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 90              UAE NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 91              SAUDI ARABIA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 92              SAUDI ARABIA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 93              SAUDI ARABIA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 94              SOUTH AFRICA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 95              SOUTH AFRICA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 96              SOUTH AFRICA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

TABLE 97              REST OF MIDDLE EAST & AFRICA NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION) 2020-2029

TABLE 98              REST OF MIDDLE EAST & AFRICA NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION) 2020-2029

TABLE 99              REST OF MIDDLE EAST & AFRICA NEUROMODULATION MARKET BY APPLICATION (USD BILLION) 2020-2029

LIST OF FIGURES

FIGURE 1              MARKET DYNAMICS

FIGURE 2              MARKET SEGMENTATION

FIGURE 3              REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4              DATA TRIANGULATION

FIGURE 5              BOTTOM-UP APPROACH

FIGURE 6              TOP-DOWN APPROACH

FIGURE 7              RESEARCH FLOW

FIGURE 8              GLOBAL NEUROMODULATION MARKET BY BIOMATERIAL, USD BILLION, 2020-2029

FIGURE 9              GLOBAL NEUROMODULATION MARKET BY TECHNOLOGY, USD BILLION, 2020-2029

FIGURE10            GLOBAL NEUROMODULATION MARKET BY APPLICATION, USD BILLION, 2020-2029

FIGURE 11           GLOBAL NEUROMODULATION MARKET BY REGION, USD BILLION, 2020-2022

FIGURE 12           PORTER’S FIVE FORCES MODEL

FIGURE 13           GLOBAL NEUROMODULATION MARKET BY BIOMATERIAL (USD BILLION), 2021

FIGURE 14           GLOBAL NEUROMODULATION MARKET BY TECHNOLOGY (USD BILLION), 2021

FIGURE 15           GLOBAL NEUROMODULATION MARKET BY APPLICATION (USD BILLION), 2021

FIGURE 16           GLOBAL NEUROMODULATION MARKET BY REGION (USD BILLION), 2021

FIGURE 17           MARKET SHARE ANALYSIS

FIGURE 18           LIVANOVA PLC: COMPANY SNAPSHOT

FIGURE 19           NEVRO CORPORATION: COMPANY SNAPSHOT

FIGURE 20           MEDTRONIC: COMPANY SNAPSHOT

FIGURE 21           NEUROSIGMA: COMPANY SNAPSHOT

FIGURE 22           NEURONETICS: COMPANY SNAPSHOT

FIGURE 23           BIOVENTUS INC.: COMPANY SNAPSHOT

FIGURE 24           NEUROPACE INC: COMPANY SNAPSHOT

FIGURE 25           MICROTRANSPONDER: COMPANY SNAPSHOT

FIGURE 26           BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

FIGURE 27           ABBOTT: COMPANY SNAPSHOT

Identifying Key Products in the Market

The identification of key products in any market is pivotal for understanding what drives consumer interest, technological innovation, and competitive advantage. Here’s how to approach this:
Market Analysis Reports: Start with syndicated market analysis reports from firms like Nielsen, Euromonitor, or specialized industry analysts. These reports often highlight leading products based on sales data, innovation, and consumer feedback.
Patent Filings: Reviewing patent filings can provide insight into technological innovations and future products that may impact the market. Databases like the United States Patent and Trademark Office (USPTO) or the World Intellectual Property Organization (WIPO) can be invaluable.
Ecommerce Platforms and Retailer Websites: Analyzing bestselling products and customer reviews on platforms such as Amazon, Flipkart, or direct retailer websites can offer direct insights into consumer preferences and product popularity.
Consumer Surveys and Feedback: Conducting surveys or analyzing online forums and social media can reveal consumer preferences, pain points, and desired features in products. Tools like SurveyMonkey, Google Surveys, or social listening platforms can facilitate this process.

Segmenting the Market and Products

Market and product segmentation is crucial for targeting marketing efforts and product development. Here’s a methodology for segmenting based on technical specifications:
Technical Specifications Review: Compile a comprehensive list of products within the market, focusing on their technical specifications. This could involve processor speeds for electronics, ingredients for food products, or material composition for apparel.
Factor Analysis: Use statistical techniques like factor analysis to group products based on shared technical specifications. This method helps identify underlying relationships between different specifications and how they cluster together.
Expert Consultation: Engage with industry experts or technical specialists to ensure that the segmentation makes sense from both a market and a technical perspective. This step ensures the practical relevance of the segments identified.

Identifying and Classifying Key Application Segments

Understanding how products are used in different applications is essential for market strategy:
Use Case Analysis: Identify common use cases for products by reviewing product literature, customer testimonials, and case studies. This helps understand the variety of applications each product serves.
Industry Surveys: Conduct surveys targeting professionals in the field to understand how and why certain products are preferred in specific applications. This can also reveal unmet needs in the market.
ApplicationBased Segmentation: Group products based on their primary applications, considering factors such as industry use, consumer vs. professional use, and environmental conditions.

Calculating Market Size Using TopDown and BottomUp Approaches

Estimating the market size accurately is fundamental for strategic planning:
TopDown Approach: Start with global industry data and narrow down to the target market by applying known market shares or segmentation percentages. Industry reports and financial databases are key sources for this approach.
BottomUp Approach: Aggregate sales data or unit shipments from all known market participants. This might require gathering data from company reports, industry associations, and sales channels.
Combining Approaches: Validate the market size estimates by comparing the results from both approaches. Discrepancies can highlight areas requiring further investigation.

Calculating the CAGR for the Market

The Compound Annual Growth Rate (CAGR) is a useful measure to understand market growth over time:
Historical Sales Data: Gather historical sales or market size data over a defined period. Public company filings, industry reports, and government databases can be sources for this data.
CAGR Formula: Apply the CAGR formula \[CAGR = (EV/BV)^{1/n} 1\], where EV is the end value, BV is the beginning value, and n is the number of periods.
Segment and Overall Market CAGR: Calculate CAGR for both the overall market and individual segments to understand growth patterns.

Sources for Secondary or Desk Research

Identifying the right sources is crucial for accurate desk research:
Industry and Market Research Reports: Sources like IBISWorld, Statista, and Frost & Sullivan offer comprehensive industry reports.
Government and International Organizations: Websites of the U.S. Census Bureau, World Bank, and OECD provide economic and industry specific data.
Academic Journals: Platforms like Google Scholar and JSTOR can offer peer reviewed articles on market trends and consumer behavior.
News Archives and Trade Publications: Stay informed on industry developments through sources like Bloomberg, Reuters, and specific trade journals relevant to the market in question.
Each of these steps requires careful consideration and a systematic approach to ensure that the market research report is robust, insightful, and actionable.

Neuromodulation Market

Base Year Value ()

CAGR ()

Forecast Year Value ()

Historical Data Period

Largest Region

Forecast Period

Neuromodulation Market By Biomaterials (Metallic, Polymeric and Ceramic Biomaterials) By Technology (Internal Neuromodulation, External Neuromodulation) and by Region Global Trends and Forecast From 2022 To 2029

Instant access to hundreds of data points and trends

Neuromodulation Market Overview

The global neuromodulation market is expected to grow at a 12.3% CAGR from 2022 to 2029, from USD 5.79 billion in 2021.

Frequently Asked Questions

• What is the worth of global neuromodulation market?

• What are the upcoming trends of neuromodulation market, globally?

• What is the CAGR of neuromodulation market?

• Which are the top companies to hold the market share in neuromodulation market?

• Which is the largest regional market for neuromodulation market?

Key Question Answered

Neuromodulation Market Segment Analysis

Neuromodulation Market Players

Who Should Buy? Or Key stakeholders

Neuromodulation Market Regional Analysis

Key Market Segments: Neuromodulation Market

Key Objectives:

LIST OF TABLES

DOWNLOAD FREE SAMPLE REPORT

License Type

Get Sample to Email

SPEAK WITH OUR ANALYST

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

In-Depth Database

Recognised Publishing Sources

Customer Support

Safe & Secure

Talk to Expert

+1 (704) 266-3234

Send an Email

Contact us

Quick Links

We accept